Carl Zeiss Meditec AG AFX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €100.10
- Day Range
- €99.00–99.00
- 52-Week Range
- —–202.00
- Bid/Ask
- €0.00 / €0.00
- Market Cap
- €8.85 Bil
- Volume/Avg
- 0 / 133,236
Key Statistics
- Price/Earnings (Normalized)
- 30.89
- Price/Sales
- 4.22
- Dividend Yield (Trailing)
- 1.11%
- Dividend Yield (Forward)
- 1.11%
- Total Yield
- 1.11%
Company Profile
Carl Zeiss Meditec is one of the largest medical technology companies in the world and it operates in two segments: Ophthalmic devices and Microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 4,823
- Website
- https://www.zeiss.com
Competitors
Valuation
|
Metric
|
AFX
|
JNJ
|
|---|---|---|
Price/Earnings (Normalized) | 30.89 | 14.07 |
Price/Book Value | 4.10 | 5.14 |
Price/Sales | 4.22 | 4.12 |
Price/Cash Flow | 23.50 | 18.53 |
Price/Earnings
AFX
JNJ
Financial Strength
|
Metric
|
AFX
|
JNJ
|
|---|---|---|
Quick Ratio | 2.41 | 0.91 |
Current Ratio | 3.40 | 1.16 |
Interest Coverage | 22.05 | 18.88 |
Quick Ratio
AFX
JNJ
Profitability
|
Metric
|
AFX
|
JNJ
|
|---|---|---|
Return on Assets (Normalized) | — | 13.98% |
Return on Equity (Normalized) | — | 35.02% |
Return on Invested Capital (Normalized) | — | 22.24% |
Return on Assets
AFX
JNJ
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Gqdbwsnj | Tmyr | $133.1 Bil | |
BDX
| Becton Dickinson & Co | Htksswwh | Qnlpdb | $66.9 Bil | |
ALC
| Alcon Inc | Gxjcytd | Bcvvyd | $38.9 Bil | |
RMD
| ResMed Inc | Thzycptv | Cmzkwwd | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Dgwdyjkkd | Cvss | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Scsyxtqy | Pnqb | $26.4 Bil | |
BAX
| Baxter International Inc | Vndblgmg | Kvtlj | $20.4 Bil | |
HOLX
| Hologic Inc | Mffzzsm | Blxrlg | $17.8 Bil | |
COO
| The Cooper Companies Inc | Jzvgfvbf | Jpvbsz | $17.7 Bil | |
TFX
| Teleflex Inc | Dsv | Bpvw | $9.7 Bil |